Symbol | Exchange | Currency |
|---|
Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company’s lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 257.00 | 258.00 | 255.00 | +0.50 | +0.20% | 2.03M | London | |||
| 300.00 | 302.00 | 299.50 | 0.00 | 0.00% | 542.37K | London | |||
| 2.25 | 2.10 | 2.10 | +0.05 | +2.27% | 1.22M | London | |||
| 37.40 | 38.80 | 37.10 | -0.10 | -0.27% | 1.62M | London | |||
| 21.33 | 21.75 | 20.38 | +0.34 | +1.62% | 3.95M | London | |||
| 175.60 | 176.15 | 171.95 | +2.75 | +1.59% | 4.28M | London | |||
| 73.16 | 75.00 | 73.16 | -1.06 | -1.43% | 3.49M | London | |||
| 1.075 | 1.075 | 1.075 | +0.075 | +7.50% | 9.58M | London | |||
| 121.58 | 122.02 | 120.48 | +0.36 | +0.30% | 24.58M | London | |||
| 159.50 | 159.80 | 149.60 | +12.50 | +8.50% | 2.42M | London | |||
| 0.20 | 0.20 | 0.20 | 0.00 | 0.00% | 0.00 | London | |||
| 380.50 | 384.50 | 376.50 | +1.00 | +0.26% | 111.63K | London | |||
| 230.00 | 230.00 | 230.00 | 0.00 | 0.00% | 0.00 | London | |||
| 219.00 | 224.60 | 218.30 | -3.20 | -1.44% | 4.61M | London | |||
| 1,651.00 | 1,682.00 | 1,645.50 | -9.50 | -0.57% | 272.76K | London |